Molecular forms of the porcine LH/CG receptor (pLHR) and complexes bet
ween hCG and either the full-length pLHR or its extracellular domain (
ectodomain) have been produced in various recombinant systems. In COS
cells and in the baculovirus insect cells system, the co-expression of
the ecto- and endo-domains reconstituted a functional receptor where
the association of the two domains seems to depend upon the presence o
f disulfide bridges. According to previous observations \39\, syntheti
c peptides mimicking three regions of the ectodomain (21-38, 100-115,
250-272) were found to inhibit hormone binding and stimulation of cAMP
production. Antisera raised against these peptides contained anti-pep
tide antibodies (Ab) able to interfere with hormone signalling. Moreov
er, the results of peptide mapping indicated that some peptide stretch
es may be more involved in signalling rather than in binding. Immunoch
emical mapping based on monoclonal antibodies (mAbs) was used to probe
the hCG-ectodomain complex. It appeared that mAbs directed to epitope
s present on the 'beta-tip' of hCG (assembled from the beta subunit lo
ops 3 and 1, and previously designated site IIIb) and on the 'alpha-ti
p' (alpha subunit loops I and 3, site IIIa) bound to hCG-receptor comp
lexes, whereas a conformational epitope (defined by the alpha-beta int
erface between beta seat belt C-terminus and alpha loop 2, site II) wa
s masked. Interestingly, we and others previously reported that, in th
e hCG-full length receptor complex, site IIIa was shielded to mAb bind
ing. A peptide mimicking the second extracellular loop (EL2) of the re
ceptor endodomain was found to prevent the binding of a mAb directed t
o site IIIa, suggesting that this region of the endodomain may be inte
racting with the 'alpha-tip'. In the full-length, membrane anchored pL
HR, the EL2 peptide inhibited hCG-induced cAMP production, but not bin
ding. The possibility of inhibiting stimulation without inhibition of
binding gives support to the 'negative specificity' hypothesis [6]. Th
us, the ectodomain of the glycoprotein hormone receptors might be cons
idered as a screening device preventing access of any glycoprotein hor
mone to the signalling peptide keys of the endodomain, which otherwise
would be sensitive to any alpha subunit stimulation. Finally, antibod
y binding to site IIIa on the hCG-ectodomain complex was also hindered
by an anti-peptide mAb directed against a peptide encoded by the eigh
th exon (pE x 8) of the LHR. This suggests that pExs is vicinal to the
alpha-tip of hCG and to EL2 in the hCG-full length receptor complex.
Altogether, these observations help to build up a topological model of
the hCG-receptor complex. Copyright (C) 1996 Elsevier Science Ireland
Ltd.